Skip to main content
Top
Published in: European Radiology 4/2019

01-04-2019 | Head and Neck

Morphological MRI-based features provide pretreatment survival prediction in glioblastoma

Authors: Julián Pérez-Beteta, David Molina-García, Alicia Martínez-González, Araceli Henares-Molina, Mariano Amo-Salas, Belén Luque, Elena Arregui, Manuel Calvo, José M. Borrás, Juan Martino, Carlos Velásquez, Bárbara Meléndez-Asensio, Ángel Rodríguez de Lope, Raquel Moreno, Juan A. Barcia, Beatriz Asenjo, Manuel Benavides, Ismael Herruzo, Pedro C. Lara, Raquel Cabrera, David Albillo, Miguel Navarro, Luis A. Pérez-Romasanta, Antonio Revert, Estanislao Arana, Víctor M. Pérez-García

Published in: European Radiology | Issue 4/2019

Login to get access

Abstract

Objectives

We wished to determine whether tumor morphology descriptors obtained from pretreatment magnetic resonance images and clinical variables could predict survival for glioblastoma patients.

Methods

A cohort of 404 glioblastoma patients (311 discoveries and 93 validations) was used in the study. Pretreatment volumetric postcontrast T1-weighted magnetic resonance images were segmented to obtain the relevant morphological measures. Kaplan-Meier, Cox proportional hazards, correlations, and Harrell’s concordance indexes (c-indexes) were used for the statistical analysis.

Results

A linear prognostic model based on the outstanding variables (age, contrast-enhanced (CE) rim width, and surface regularity) identified a group of patients with significantly better survival (p < 0.001, HR = 2.57) with high accuracy (discovery c-index = 0.74; validation c-index = 0.77). A similar model applied to totally resected patients was also able to predict survival (p < 0.001, HR = 3.43) with high predictive value (discovery c-index = 0.81; validation c-index = 0.92). Biopsied patients with better survival were well identified (p < 0.001, HR = 7.25) by a model including age and CE volume (c-index = 0.87).

Conclusions

Simple linear models based on small sets of meaningful MRI-based pretreatment morphological features and age predicted survival of glioblastoma patients to a high degree of accuracy. The partition of the population using the extent of resection improved the prognostic value of those measures.

Key Points

• A combination of two MRI-based morphological features (CE rim width and surface regularity) and patients’ age outperformed previous prognosis scores for glioblastoma.
• Prognosis models for homogeneous surgical procedure groups led to even more accurate survival prediction based on Kaplan-Meier analysis and concordance indexes.
Appendix
Available only for authorised users
Literature
2.
go back to reference Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: Images Are More than Pictures, They Are Data. Radiology 278(2):563–577CrossRefPubMed Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: Images Are More than Pictures, They Are Data. Radiology 278(2):563–577CrossRefPubMed
3.
go back to reference Narang S, Lehrer M, Yang D, Lee J, Rao A (2016) Radiomics in glioblastoma: current status, challenges and opportunities. Transl Cancer Res 5(4):383–397 Narang S, Lehrer M, Yang D, Lee J, Rao A (2016) Radiomics in glioblastoma: current status, challenges and opportunities. Transl Cancer Res 5(4):383–397
4.
go back to reference Ellingson BM, Bendszus M, Sorensen AG, Pope WB (2014) Emerging techniques and technologies in brain tumor imaging. Neuro Oncol 16(7):12–23 Ellingson BM, Bendszus M, Sorensen AG, Pope WB (2014) Emerging techniques and technologies in brain tumor imaging. Neuro Oncol 16(7):12–23
5.
go back to reference Ellingson BM (2015) Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep 15(1):506CrossRefPubMed Ellingson BM (2015) Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep 15(1):506CrossRefPubMed
6.
go back to reference Pérez-Beteta J, Martínez-González A, Molina D et al (2017) Glioblastoma: Does the pretreatment geometry matter? A postcontrast T1 MRI-based study. Eur Radiol 27:1096–1104CrossRefPubMed Pérez-Beteta J, Martínez-González A, Molina D et al (2017) Glioblastoma: Does the pretreatment geometry matter? A postcontrast T1 MRI-based study. Eur Radiol 27:1096–1104CrossRefPubMed
7.
go back to reference Abrol S, Kotrotsou A, Salem A, Zinn PO, Colen RR (2017) Radiomic phenotyping in brain cancer to unravel hidden information in medical images. Top Magn Reson Imaging 26(1):43–53 Abrol S, Kotrotsou A, Salem A, Zinn PO, Colen RR (2017) Radiomic phenotyping in brain cancer to unravel hidden information in medical images. Top Magn Reson Imaging 26(1):43–53
8.
go back to reference Cui Y, Tha KK, Teresaka S et al (2016) Prognostic imaging biomarkers in glioblastoma: Development and independent validation on the basis of multiregion and quantitative analysis of MR images. Radiology 278(2):546–553CrossRefPubMed Cui Y, Tha KK, Teresaka S et al (2016) Prognostic imaging biomarkers in glioblastoma: Development and independent validation on the basis of multiregion and quantitative analysis of MR images. Radiology 278(2):546–553CrossRefPubMed
9.
go back to reference Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA et al (2018) Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology 288(1):218–225 Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA et al (2018) Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology 288(1):218–225
10.
go back to reference Cui Y, Ren S, Tha KK, Wu J, Shirato H, Li R (2017) Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Eur Radiol 27(9):3583–3592 Cui Y, Ren S, Tha KK, Wu J, Shirato H, Li R (2017) Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Eur Radiol 27(9):3583–3592
11.
go back to reference Kickingereder P, Burth S, Wick A et al (2016) Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models. Radiology 280(3):880–889CrossRefPubMed Kickingereder P, Burth S, Wick A et al (2016) Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models. Radiology 280(3):880–889CrossRefPubMed
12.
13.
go back to reference Wangaryattawanich P, Hatami M, Wang J et al (2015) Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol 17(11):1525–1537CrossRefPubMedPubMedCentral Wangaryattawanich P, Hatami M, Wang J et al (2015) Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol 17(11):1525–1537CrossRefPubMedPubMedCentral
14.
go back to reference Ingrisch M, Schneider MJ, Nörenberg D et al (2017) Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma. Invest Radiol 52(6):360–366CrossRefPubMed Ingrisch M, Schneider MJ, Nörenberg D et al (2017) Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma. Invest Radiol 52(6):360–366CrossRefPubMed
15.
go back to reference Ellingson BM, Harris RJ, Woodworth DC et al (2017) Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro Oncol 19(1):89–98CrossRefPubMed Ellingson BM, Harris RJ, Woodworth DC et al (2017) Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro Oncol 19(1):89–98CrossRefPubMed
16.
go back to reference Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996CrossRefPubMed Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996CrossRefPubMed
17.
go back to reference Grabowsky MM, Recinos PF, Nowacki AS et al (2014) Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 121:1115–1123CrossRef Grabowsky MM, Recinos PF, Nowacki AS et al (2014) Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 121:1115–1123CrossRef
18.
go back to reference Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13(12):1339–1348 Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13(12):1339–1348
19.
go back to reference Chaichana KL, Jusue-Torres I, Lemos AM et al (2014) The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol 120(3):625–634CrossRefPubMedPubMedCentral Chaichana KL, Jusue-Torres I, Lemos AM et al (2014) The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol 120(3):625–634CrossRefPubMedPubMedCentral
20.
go back to reference Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124(4):977–988 Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124(4):977–988
21.
go back to reference Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:109–198CrossRef Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:109–198CrossRef
23.
go back to reference Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(1):2543–2546 Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(1):2543–2546
24.
go back to reference Cordova JS, Gurbani SS, Holder CA et al (2016) Semi-automated volumetric and morphological assessment of glioblastoma resection with fluorescence-guided surgery. Mol Imaging Biol 18:454–462CrossRefPubMedPubMedCentral Cordova JS, Gurbani SS, Holder CA et al (2016) Semi-automated volumetric and morphological assessment of glioblastoma resection with fluorescence-guided surgery. Mol Imaging Biol 18:454–462CrossRefPubMedPubMedCentral
25.
go back to reference Molina D, Pérez-Beteta J, Martínez-González A et al (2017) Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization. PLoS One 12(6):e0178843CrossRefPubMedPubMedCentral Molina D, Pérez-Beteta J, Martínez-González A et al (2017) Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization. PLoS One 12(6):e0178843CrossRefPubMedPubMedCentral
26.
go back to reference Pérez-García VM, Calvo GF, Belmonte-Beitia J, Diego D, Pérez-Romasanta L (2011) Bright solitary waves in malignant gliomas. Phys Rev E Stat Nonlin Soft Matter Phys 84:021921 Pérez-García VM, Calvo GF, Belmonte-Beitia J, Diego D, Pérez-Romasanta L (2011) Bright solitary waves in malignant gliomas. Phys Rev E Stat Nonlin Soft Matter Phys 84:021921
27.
go back to reference Anderson AR, Weaver A, Cummings PT, Quaranta V (2006) Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127:905–915 Anderson AR, Weaver A, Cummings PT, Quaranta V (2006) Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127:905–915
28.
go back to reference Martin M (2008) Comparing invasive species to metastatic cancers inspires new insights for modelers. J Natl Cancer Inst 100:88 Martin M (2008) Comparing invasive species to metastatic cancers inspires new insights for modelers. J Natl Cancer Inst 100:88
29.
go back to reference Henker C, Kriesen T, Glass Ä, Schneider B, Piek J (2017) Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival. J Neurooncol 135:391–402 Henker C, Kriesen T, Glass Ä, Schneider B, Piek J (2017) Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival. J Neurooncol 135:391–402
30.
go back to reference Gittleman H, Lim D, Kattan MW et al (2017) An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol 19(5):669–677PubMed Gittleman H, Lim D, Kattan MW et al (2017) An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol 19(5):669–677PubMed
31.
go back to reference Chung C (2015) Imaging biomarkers in preclinical studies on brain tumors. In: Preedy V, Patel V (eds) Biomarkers in cancer. Biomarkers in disease: methods, discoveries and applications. Springer, Dordrecht Chung C (2015) Imaging biomarkers in preclinical studies on brain tumors. In: Preedy V, Patel V (eds) Biomarkers in cancer. Biomarkers in disease: methods, discoveries and applications. Springer, Dordrecht
33.
go back to reference Grossmann P, Gutman DA, Dunn WD Jr, Holder CA, Aerts HJ (2016) Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma. BMC Cancer 16:611CrossRefPubMedPubMedCentral Grossmann P, Gutman DA, Dunn WD Jr, Holder CA, Aerts HJ (2016) Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma. BMC Cancer 16:611CrossRefPubMedPubMedCentral
Metadata
Title
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma
Authors
Julián Pérez-Beteta
David Molina-García
Alicia Martínez-González
Araceli Henares-Molina
Mariano Amo-Salas
Belén Luque
Elena Arregui
Manuel Calvo
José M. Borrás
Juan Martino
Carlos Velásquez
Bárbara Meléndez-Asensio
Ángel Rodríguez de Lope
Raquel Moreno
Juan A. Barcia
Beatriz Asenjo
Manuel Benavides
Ismael Herruzo
Pedro C. Lara
Raquel Cabrera
David Albillo
Miguel Navarro
Luis A. Pérez-Romasanta
Antonio Revert
Estanislao Arana
Víctor M. Pérez-García
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 4/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5758-7

Other articles of this Issue 4/2019

European Radiology 4/2019 Go to the issue